GenCure completes 80-litre stem cell production run
The run hugely scales up human mesenchymal stem cells production with two more runs planned to refine the process
Breaking News
Samsung BioLogics implements large scale N-1 perfusion
An Alternating Tangential Flow (ATF) device was used to reduce production time by 30% in a commercial production process
3P Biopharmaceuticals finds major new investor
The CDMO specialises in the process development and GMP manufacturing of biologics
PE firm acquires Aldevron
The CDMO from North Dakota has additional operations in Madison, Wisconsin, and Freiburg, Germany
Process optimisation with flow chemistry
WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...
Halix begins viral vector production at new Dutch GMP facility
The new 6,700 sqm cGMP facility is in Leiden Bio Science Park just north of Rotterdam
University in Virginia starts first US pharma engineering PhD
Qualification will train students in manufacturing procedures focusing on areas of drug product development such as ...
Case Study: Phase I to commercial in 18 months
Druggability Technologies CEO, Gabor Heltovics, talks about using Quotient Sciences to progress and scale-up an ...
Mezzan Holdings acquires only pharma manufacturer in Kuwait
The 67% stake in the company was bought for around US$69 million
Brammer Bio in talks to build manufacturing site in Massachusetts
The US cell and gene therapy CDMO expects to employ around 300 people at the plant by 2021
Small molecule CDMOs reacting to changing market demands
The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...
Stainless steel products in contemporary bioprocessing
ASEPCO's Mark Embury on the shift from stainless steel to single-use systems in the pharmaceutical manufacturing sector
WuXi Biologics CEO: Vaccine CDMO is the next area of growth
Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion
Olon begins construction on new GMP API facility in Italy
The construction of the CDMO's new GMP facility is associated with a long-term strategic partnership with a large ...
Omeros chooses Lonza to transition from clinical to commercial supply
The new multi-year agreement secures a source of commercial quantities of narsoplimab for use following anticipated ...
In Brief
Most Popular in Contract Manufacturing
- Recipharm to acquire two CDMO businesses from Kemwell for SEK1.7bn
- Mylan launches first bioequivalent alternative to combination asthma therapy Seretide Evohaler
- Sanofi and Pfizer engage Biovac Institute with vaccines production in South Africa
- Contract manufacturing in India grows at 20%
- 3P Biopharmaceuticals finds major new investor
Suppliers in contract manufacturing
Reports
